Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D00RUN
|
|||
Former ID |
DNC011643
|
|||
Drug Name |
4-(7,7-Dimethyl-oct-3-ynyl)-1H-imidazole
|
|||
Synonyms |
CHEMBL280076; 4-(7,7-Dimethyl-oct-3-ynyl)-1H-imidazole; 1H-Imidazole, 5-(7,7-dimethyl-3-octyn-1-yl)-; SCHEMBL7619037; PDSP1_000108; BDBM50070214; PDSP2_000108; GT 2293; 209599-16-6
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C13H20N2
|
|||
Canonical SMILES |
CC(C)(C)CCC#CCCC1=CN=CN1
|
|||
InChI |
1S/C13H20N2/c1-13(2,3)9-7-5-4-6-8-12-10-14-11-15-12/h10-11H,6-9H2,1-3H3,(H,14,15)
|
|||
InChIKey |
CNQBABLURIQXNU-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Histamine H3 receptor (H3R) | Target Info | Inhibitor | [1] |
KEGG Pathway | Neuroactive ligand-receptor interaction | |||
Reactome | Histamine receptors | |||
G alpha (i) signalling events | ||||
WikiPathways | Monoamine Transport | |||
GPCRs, Class A Rhodopsin-like | ||||
GPCR ligand binding | ||||
GPCR downstream signaling |
References | Top | |||
---|---|---|---|---|
REF 1 | New acetylene based histamine H3 receptor antagonists derived from the marine natural product verongamine. Bioorg Med Chem Lett. 1998 May 19;8(10):1133-8. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.